Agilent Technologies (A) FY2025 10-K Annual Report

Filed: Dec 22, 2025
Health Care
Laboratory Analytical InstrumentsSEC EDGAR

Agilent Technologies (A) 10-K annual report for fiscal year 2025, filed with SEC EDGAR on Dec 22, 2025. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.

Agilent Technologies FY2025 10-K Analysis

Business Overview

  • Core business model: Provider of scientific instruments and analytical solutions for laboratories and research
  • No new products, services, or business segments introduced or emphasized in this year's filing
+3 more insights

Management Discussion & Analysis

  • Revenue and profitability figures not disclosed in provided MD&A text
  • No segment performance data provided in excerpt
+2 more insights

Risk Factors

  • Regulatory risk from Inflation Reduction Act 2022, 1% nondeductible excise tax on stock repurchases payable, $3 million recorded in fiscal 2025
  • Geopolitical risk from U.S. tariff changes in H2 2025 increasing cost of revenue; mitigation expected in fiscal 2026 through supply chain and pricing actions
+3 more insights

Agilent Technologies FY2025 Key Financial Metrics
XBRL

Revenue

$6.9B

+6.7% YoY

Net Income

$1.3B

+1.1% YoY

Operating Margin

21.3%

-157bp YoY

Net Margin

18.8%

-105bp YoY

ROE

19.3%

-253bp YoY

Total Assets

$12.7B

+7.4% YoY

EPS (Diluted)

$4.57

+3.2% YoY

Operating Cash Flow

$1.6B

-11.0% YoY

Source: XBRL data from Agilent Technologies FY2025 10-K filing on SEC EDGAR. All figures in USD.

Get deeper insights on Agilent Technologies

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.